LF 501
Alternative Names: LF-501Latest Information Update: 22 Sep 2023
At a glance
- Originator Lifex Biolabs
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Breast cancer; Lung cancer
Most Recent Events
- 19 Jul 2023 Early research in Breast cancer in USA (PO) before July 2023 (Lifex Biolabs pipeline, July 2023)
- 19 Jul 2023 Early research in Lung cancer in USA (PO) before July 2023 (Lifex Biolabs pipeline, July 2023)